Events
This was 1 year ago
Prague, Czech Republic
The EU Research and Innovation (R&I) programme Horizon Europe and the Common Agricultural Policy (CAP) work in synergy under the common concept of the EIP-AGRI to stimulate co-creation and the exchange of knowledge and innovation in agriculture, forestry and rural areas.
This event aims to inform and match interested parties in the calls of the different agricultural innovation programmes. The full programme and registration details can be found here.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
After the success of the previous editions, NCP Flanders announces the 5th edition of the “Horizon Europe proposal workshop”, organised by Horizon Europe National Contact Points NCP Federal BE, NCP-FNRS, NCP Wallonie & NCP Flanders.The target audience is limited to researchers and staff members of federal or...
Read moreThis webinar is organised by the European Innovation Council and SMEs Executive Agency through the European IP Helpdesk. The webinar will cover the background and purpose of the EU AI Act, key provisions and requirements, compliance and implementation, ethical and social considerations, case studies, and possible...
Read moreThis awareness-raising event will highlight the importance of international cooperation in Cluster 6 and give applicants insight into the opportunities and challenges of building international partnerships. The programme includes: An overview of international cooperation opportunities and main considerations Interviews with Cluster 6...
Read moreThe European Commission organises an online information session on the Horizon Europe call for proposals on the EU AI Media Platform (HORIZON-BRIDGING-2027-01-09). The topic is about modular multilingual public-interest infrastructure for European news and audiovisual media. This online session is aimed at media organisations,...
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
